Frontlight ResearchEarly access
TerminatedPhase 4
Effect of Continuing Versus Holding Metformin During Hospitalizations.
Key facts
- Who runs it
- University of Illinois Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Terminated
- Phase
- Phase 4
- People taking part
- 22 people enrolled
- Started
- 21 Jan 2025
- Ended
- 30 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Metformin
- Record updated
- 17 June 2026
- Why it stopped
- Low recruitment rate and an inability to meet power.
Who can take part
- Age
- 18 years to 110 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adult (18+ years of age)
- Admitted to an internal medicine service
- On Metformin prior to admission
Who cannot take part
- Inability to take oral medications
- Acute Decompensated Heart Failure
- eGFR < 30 ml/min/1.73 m2
- Dialysis
- Current Acidosis (pH < 7.35) including diabetic ketoacidosis
- Child-Turcotte-Pugh class C hepatic cirrhosis
- Cognitively impaired and/or unable to consent
- Lack of or unwillingness to share contact information
- Pregnant women
Where in United States
- University of Illinois at ChicagoChicago, United States
About the trial
What the trial wants to find out
A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.
The 2 groups in the trial
- Metformin continuationExisting treatment, for comparison
Continuation of home metformin regimen during hospitalization to an internal medicine service
Treatment: Metformin
- Metformin discontinuationNo study treatment, for comparison
Holding home metformin regimen during hospitalization to an internal medicine service
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Continuing Versus Holding Metformin During Hospitalizations to Internal Medicine on Glucose Control, Acidosis, Abdominal Symptoms, Length of Stay, and Mortality.
- Record updated
- 17 June 2026